Skip to main content

Institute for Global Health (IGH)

About the IGH

The IGH, established in 2015 at the University of Maryland School of Medicine, is dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world.

A Global Foot Print:
Current Research and Development

(mouse over red markers  to learn about each of our global research projects)

Click Here for a full-screen map

Within the IGH is the Center for Vaccine Development (CVD), which is led by Kathleen Neuzil, MD, MPH, and the Division of Malaria Research, which under the leadership of Miriam Laufer, M.D.

For over 40 years, CVD has worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.The Division of Malaria Research performs the crucial work needed to support global malaria eradication. That work includes developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. The IGH is an instrumental partner in international initiatives to eliminate malaria in Africa and other parts of the world. 

With more than 30 faculty physicians and scientists, the IGH collaborates with other School of Medicine institutes, centers, departments and programs, as well as other schools on campus, and other entities within the University System of Maryland.

Give to IGH

Kathleen M. Neuzil, MD, MPH, FIDSA
IGH Interim Director

Connect with IGH

IGH News

Global Health Seminar

Virginia Elizabeth Pitzer, ScD, Co-Director, Public health Modeling Concentration at Yale School of Public Health

Dr. Pitzer will discuss: Typhoid Fever: Modeling the Impact of New Strategies Against an Old Foe.

March 19, 2018 at noon
HSFII Auditorium
20 Penn Street

IGH News